CARLA ROTHMANN: Open Payments
NPI 1649793506 · DELTAVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 23 payments from 11 companies in 2025. Trend: 2023 $259 · 2024 $95 · 2025 $528
Food & beverage: $509Education: $19
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $252 |
| PFIZER INC. | 3 | $51 |
| Ascendis Pharma Endocrinology Inc | 2 | $42 |
| Lilly USA, LLC | 2 | $35 |
| ABBVIE INC. | 2 | $31 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Boston Scientific Corporation | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
Products named: AIRSUPRA, FARXIGA, Yorvipath, MOUNJARO, NURTEC ODT, UBRELVY, VAXELIS, PREVNAR 20.
Industry payments across VA — which companies pay providers there.
